Akumentis Healthcare Limited is an Indian pharmaceutical company with its headquarters in Thane, Maharashtra, India. The company was founded jointly by Rajaram Samant, Sandeep Jain and Sanjeev Jain in the year. Akumentis Healthcare was incorporated on the 29th of July in the year 2010. Samant had worked initially in companies like Ranbaxy, Emcure and Wanbury. At the time of its inception, the company was mainly involved in the therapy areas of women healthcare and orthopedics and this was one of the main reasons for the spurt in its growth. The company experienced rough times throughout its development since its beginning in the year 2010 before making it to the list of top fifty companies just three years after it started operations. It had already entered the list of top sixty-five companies after it completed its first year. The company was awarded by the Ministry of Commerce as the ‘Emerging Company of the Year 2012’. While Rajaram Samant made an exit from the company in the year 2020, Sandeep Jain and Sanjeev Jain are still a part of it. Pradeep Patni is currently serving as CEO after Rajaram Samant’s exit from Akumentis Healthcare Limited.

The company specializes in the therapy areas of women healthcare with infertility management, obstetrics, gynecology and osteoporosis being included in it. Apart from this, the company is involved in the segments of orthopedic, pain and inflammation management, pediatrics and geriatrics nutrition, gastroenterology, ophthalmology, dental care, cardiology, diabetology, nephrology, central nervous system, cosmetology, dermatology and acute and chronic infection.

Akumentis Healthcare Limited manufactures its products with the help of agreements signed with Akums Drugs and Pharmaceuticals Limited, which is a popular contract manufacturer of pharmaceutical products and also the parent company of Akumentis. It has multiple manufacturing facilities located in Haridwar, India. Akumentis Healthcare Limited has its own manufacturing facilities which work in accordance with international standards and have received approval from major international regulatory bodies. The company also has research facilities across the country.

Some of the top products of the company are ALL 9, ROSYCAP-GOLD, FIBROEASE, BENITOWA, LINEATOR, ROSYCAP-ASP, SWITGLIM-M, FIBRISTAL, NEWBONA ACTIVE, ALIVHER, MET-PCO CARE, OOSURE-M, SWITGLIM-MV, NEWBONA PLUS, ALL 9-D, MICHELLE, TENELIGLIP M, ROSYCAP, SEACURE, IBROPRIST, BENITOWA-TM, FIBRONORM, FINENERVE NT, TENELIGLIP, ZEROSTIFF TOTAL, NEWBONA FEM, CLOMIPURE, GOODOVA, KILFAT, ROSYCAP-CV, PMSFINE, FORMITOL, CALCINEW, F029, BERBESHINE, BENITOWA-BETA, STARMUNE GOLD, FINENERVE, GEMIKING, ENDOHEAL, NEWBONA JELLY, DOLENTIA RELAX, OVAFEM PLUS, SWITGLIM-MP, OOSURE FORTE, CERVIFERT, PCO CARE, HAEMADAY, MASTERCAL and AMIKAFINE.